 |
|
May 15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Amneal: Receives U.S. FDA Approval for
Brekiya (dihydroergotamine mesylate) Injection
for the Acute Treatment of Migraine and
Cluster Headaches in Adults More
- Merck: FDA Approves WELIREG
(belzutifan) for the Treatment of Adults and
Pediatric Patients 12 Years and Older With
Locally Advanced, Unresectable, or
Metastatic Pheochromocytoma or Paraganglioma
(PPGL) More
More*
- Merck: Phase 3 KEYNOTE-B96 Trial Met Primary
Endpoint of Progression-Free Survival (PFS) in
Patients With Platinum-Resistant Recurrent
Ovarian Cancer Whose Tumors Expressed PD-L1
and in All Comers More
- Mesoblast: FDA Provides Seven Years
of Orphan-Drug Exclusive Approval for
Ryoncil More
- NS Pharma: FDA Accepts Biologics License
Application for Mucopolysaccharidosis II
Treatment More
|
|
- atai Life Sciences: First Quarter 2025
Financial Results and Recent Corporate Updates
More
- BioRestorative Therapies: First Quarter 2025
Financial Results and Business Update More
- Citius Oncology: Fiscal Second Quarter 2025
Financial Results and Business Update More
- CytoSorbents: First Quarter 2025 Financial
Results and Business Update More
- Glucotrack: First Quarter 2025 Financial
Results and Recent Corporate Highlights More
- Indaptus Therapeutics: First Quarter 2025
Financial Results and Corporate Update More
- Kamada: Strong First Quarter 2025 Financial
Results With Year Over Year Top Line Growth of
17% and a 54% Increase in Profitability
More
- Lucid Diagnostics: Business Update and First
Quarter 2025 Financial Results More
More*
- MiNK Therapeutics: Q1 2025 Results and
Clinical & Strategic Progress More
- More on Axsome Entering in $570
Million Loan and Revolving Credit Facility
With Blackstone More*
- Quest Diagnostics: Quarterly Cash Dividend
More
- Sanofi: To Invest at Least $20
Billion in the US Through 2030, Growing
Investments in Science and Expanding
Domestic Manufacturing More
|
|
|
- Leveraging Synergies: How a Merger
Provides Speed, Flexibility, and a Unified
Offering for Customers Podcast
- More on Synchron Enabling Thought Control of
Apple Devices With Brain Implant More
- Plenty of Promise in Pfizer’s ASCO Offering
More*
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
highlighted on our
website. |
|
|
|
|
|
|
NOTE: EVENTS AND JOBS ARE FROM
ALL BIG4BIO REGIONS
 |
|
Premier Executive Search and
Talent Advisory Firm Slone
Partners Launches Fractional
Talent Service to Deliver
On-Demand Leaders and Specialists
|
|
Learn More
→ |
|
|
- OPPORTUNITY: Chief Executive Officer More
- OPPORTUNITY: Chief Product Officer More
- OPPORTUNITY: Vice President, Digital Health
Business Development More
- OPPORTUNITY: Chief Business Officer More
- OPPORTUNITY: Vice President, Finance More
- OPPORTUNITY: Director, Compliance &
Quality Systems
More
- OPPORTUNITY: West Coast Business Development
Director
More
- OPPORTUNITY: Chief Financial Officer More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
